Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF‐κB‐dependent transcriptional control of α2,3‐sialyltransferase I, II, and VI in human castration‐resistant prostate cancer cells

@article{Hatano2011ExpressionOG,
  title={Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF‐$\kappa$B‐dependent transcriptional control of $\alpha$2,3‐sialyltransferase I, II, and VI in human castration‐resistant prostate cancer cells},
  author={Koji Hatano and Yasuhide Miyamoto and Norio Nonomura and Yasufumi Kaneda},
  journal={International Journal of Cancer},
  year={2011},
  volume={129}
}
Gangliosides are sialic acid–containing glycosphingolipids that are associated with tumor malignancy and progression. Among the enzymes required for the production of gangliosides, sialyltransferases have received much attention in terms of their relationship with cancer. In our previous report, ganglioside GD1a and sialyl paragloboside (SPG), a neolacto‐series ganglioside, were much more abundant in PC3 and DU145 cells, castration‐resistant prostate cancer cells, as compared with hormone… 
Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells
TLDR
It is demonstrated that GD1a was produced in abundance in cancerous tissue samples from human patients with hormone-sensitive prostate cancers as well as castration-resistant prostate cancers, and this is the first report indicating that the expression of a sialyltransferase is transcriptionally regulated by androgen-dependent demethylation of the CpG sites in its gene promoter.
B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2
TLDR
It is concluded that B4GALNT1, and consequently GM2/GD2, enhanced tumorigenesis via induction of angiogenesis, AIG, and cell motility, which may lead to development of novel therapy for refractory melanoma.
Control of expression of glycosyltransferases involved in O-linked glycosylation in breast cancer
Aberrant glycosylation is a common phenotypic change observed in malignancy. Changes in mucin-type O-glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated
Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression.
TLDR
It is shown that altered sialyltransferase expression in cancer, consequence of genetic and epigenetic alterations, generates a flow of information toward the membrane through the biosynthesis of aberrantly sialistic molecules, which can exacerbate the neoplastic phenotype.
Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression
TLDR
Recent studies on aberrant expression and distribution of GSLs in common human cancers (breast, lung, colorectal, melanoma, prostate, ovarian, leukemia, renal, bladder, gastric, and gastric) are summarized.
Gangliosides in Cancer Cell Signaling.
TLDR
This chapter summarizes the current knowledge of ganglioside biosynthesis, degradation, and of their role in cell signaling regulation in cancers.
Glycosylation Changes in Prostate Cancer Progression
TLDR
The clinical utility and potential impact of exploiting glycans as both biomarkers and therapeutic targets to improve the ability to diagnose clinically relevant tumors as well as expand treatment options for patients with advanced disease are emphasized.
Bisecting-GlcNAc on Asn388 is characteristic to ERC/mesothelin expressed on epithelioid mesothelioma cells
TLDR
Results suggest that this glycoproteome could serve as a potential target for the generation of a highly selective and safe therapeutic antibody for epithelioid mesothelioma.
13‐Cis retinoic acid can enhance the antitumor activity of non‐replicating Sendai virus particle against neuroblastoma
TLDR
HVJ‐E is a promising therapeutic modality for neuroblastoma and 13cRA can be used as an adjuvant to HVJ •E, which could achieve partial eradication of the xenograft and lead to an improved prognosis.
A Novel Method for the Production of Glycosphingolipids
Neolacto-series ganglioside sialylparagloboside (SPG) is a ganglioside species present in various human tissues, and used in many important studies. In this study, four ganglioside analogs, GM3, GD3,
...
1
2
3
4
...

References

SHOWING 1-10 OF 65 REFERENCES
Human α2,3-Sialyltransferase (ST3Gal II) Is a Stage-specific Embryonic Antigen-4 Synthase*
TLDR
This study indicates that ST3Gal II is a MSGb5 (stage-specific embryonic antigen-4) synthase and that its increased expression level is closely related to renal carcinogenesis.
Ganglioside GD1alpha functions in the adhesion of metastatic tumor cells to endothelial cells of the target tissue.
TLDR
The functional role of GD1alpha in H10 cells in the adhesion of the tumor cells to the target tissue by using hepatic sinusoidal endothelial (HSE) cells is investigated, and data indicate that GD1 alpha functions as an adhesion molecule in the process of metastasis of H 10 cells.
Molecular Cloning of a Novel α2,3-Sialyltransferase (ST3Gal VI) That Sialylates Type II Lactosamine Structures on Glycoproteins and Glycolipids*
TLDR
Data indicated that this enzyme is involved in the synthesis of sialyl-paragloboside, a precursor of sIALyl-Lewis X determinant, as well as other novel CMP-NeuAc:β-galactoside α2,3-sialyltransferase subfamily members.
Endogenous immune response to gangliosides in patients with confined prostate cancer
Our study investigated whether endogenous IgM antibodies to gangliosides occur in patients with early stages of prostate cancer (CaP) patients, after defining ganglioside profiles of CaP cell lines.
ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
TLDR
ST3Gal.I plays the major role in the sialylation of the T antigen in bladder cancer and seems to be part of the initial oncogenic transformation of bladder and can be considered when predicting cancer progression and recurrence.
NFκB-p65 Dependent Transcriptional Regulation of Glycosyltransferases in Human Colon Adenocarcinoma HT-29 by Stimulation with Tumor Necrosis Factor α
TLDR
Results indicated that constitutive promoter activities were detected at nt −120 5′-flanking translation initiation site and TNFα enhanced ST3Gal I gene expression through NFκB binding sites in HT-29 cells.
NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha.
TLDR
Results indicated that constitutive promoter activities were detected at nt -120 5'-flanking translation initiation site and TNFalpha enhanced ST3Gal I gene expression through NFkappaB binding sites in HT-29 cells.
Characterization of Mouse Sialyltransferase Genes: Their Evolution and Diversity
  • S. Takashima
  • Biology, Medicine
    Bioscience, biotechnology, and biochemistry
  • 2008
TLDR
Analysis of the amino acid sequence similarities, substrate specificities, and gene structures of mouse sialyltransferases has revealed that they can be further divided into seven subfamilies, and the genomic structural resemblance of members of the same subfamily suggests that they arose from a common ancestral gene through gene duplication events.
Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
TLDR
Comparison of the gangliosides associated with normal and neoplastic prostate epithelial cells, organ-confined versus metastatic, and AR-negative versus AR-positive CaP cell lines enabled comparison of the androgen-receptor (AR)-negative cell line, which makes HH870 a potential component of a polyvalent-vaccine for active-specific immunotherapy of CaP.
Gene Structure and Transcriptional Regulation of Human Gal β1,4(3) GlcNAc α2,3-Sialyltransferase VI (hST3Gal VI) Gene in Prostate Cancer Cell Line
TLDR
The results suggested that the hST3Gal VI gene is expressed specifically by alternative promoter utilization and is regulated in a tissue-restricted fashion at the level of transcription.
...
1
2
3
4
5
...